Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell CarcinomaMatthew S. Davids, Boon Cher Goh, Kevin Laubscher et al.|Journal of Clinical Oncology|2009Cited by 81
MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaLi Ren Kong, Boon Cher Goh|Molecular Cancer Therapeutics|2015Cited by 51
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignanciesStephen Jun Fei Chong, Matthew S. Davids, Fen Zhu et al.|Journal of Clinical Investigation|2023Cited by 43